# A Study of LY3437943 in Chinese Participants With Obesity Or Overweight

> **NCT05548231** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 32 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** LY3437943
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05548231
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-24
- **Primary completion:** 2023-07-27
- **Final completion:** 2023-07-27
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05548231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05548231, "A Study of LY3437943 in Chinese Participants With Obesity Or Overweight". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05548231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*